You are here: Industry Insights > anticoagulant

News List

AcelRx Pharmaceuticals to Acquire Lowell Therapeutics AmericanPharmaceuticalReview
November 17, 2021
AcelRx Pharmaceuticals, a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for use in medically supervised settings...
NIH launches last trial of anticoagulant treatments for Covid-19 pharmaceutical-technology
March 10, 2021
The US National Institutes of Health (NIH) has initiated the last of three Phase III clinical trials of blood thinners (anticoagulant) to prevent life-threatening blood clots in adults with Covid-19.
PPI Use for Up to Three Years Safe During Anticoagulant Tx drugs
June 18, 2019
PPI Use for Up to Three Years Safe During Anticoagulant Tx.
FDA Approves Fragmin (dalteparin sodium) as First Anticoagulant for Venous Thromboembolism in Pediatric Patients drugs
May 22, 2019
FDA Approves Fragmin (dalteparin sodium) as First Anticoagulant for Venous Thromboembolism in Pediatric Patients.
FDA approves first anticoagulant (blood thinner) for pediatric patients to treat potentially life-threatening blood clots worldpharmanews
May 17, 2019
FDA approves first anticoagulant (blood thinner) for pediatric patients to treat potentially life-threatening blood clots.
Direct anticoagulants associated with increased risk of bleeding europeanpharmaceuticalreview
April 19, 2019
Results of a study suggest the need for caution in the prescription of direct oral anticoagulants for patients with chronic kidney disease, due to the risk of bleeding…
Chinese heparin maker banned by EMA over contamination risks fiercepharma
December 04, 2018
World regulators are cautious about crude heparin after China-made APIs were responsible for dozens of deaths in the U.S. more than a decade ago.